Clinical Trial Update: Seroquel in Acute Mania: Study to Investigate if Valproate Add-On Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing add-on valproate therapy to quetiapine monotherapy in acutely manic bipolar disorder patients; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• SEROQUEL (QUETIAPINE)
• Valproate (valproate)

Snippet

Sponsor: AstraZeneca | Conditions: Bipolar Disorder | Phase 4 | Status: TERMINATED